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Heparan  sulfate  proteoglycans (HSPG) l  are  important  components  of the 
glomerular basement membrane (GBM) (1, 2). Evidence has been obtained that 
the  integrity of HSPG  is essential  for maintaining both  the charge and size- 
selective properties of the GBM  (1-3),  and disturbances in glomerular HSPG 
have been described in association with several glomerular diseases (3-5). More- 
over, autoantibodies against HSPG have been detected in  the sera of patients 
with poststreptococcal glomerulonephritis (6). 
Recently we have raised a polyclonal antibody [anti-HSPG(GBM)] that specif- 
ically recognizes the core protein of a population of HSPG (Mr =  130,000) found 
in the GBM (7, 8) and in other renal basement membranes (5,  8), and we have 
shown  that  these antibodies bind  to  the  laminae rarae of the rat  GBM  after 
intravenous injection (8).  The findings showed that the core proteins of these 
HSPG, like their anionic glycosaminoglycan side chains (9,  10),  are exposed to 
circulating macromolecules in the glomerulus, and they raised the possibility that 
HSPG might be involved in the pathogenesis of autoimmune diseases affecting 
glomeruli. 
In  this  study  we  have  injected  anti-HSPG(GBM)  IgG  into  rats  and  have 
determined the pathologic consequences of antibody binding to  the GBM  at 
selected intervals  up  to  2  mo  thereafter.  We  were particularly  interested  in 
determining whether binding of antibodies to fixed, endogenous antigens con- 
centrated in the laminae rarae of the GBM would lead to an immune complex- 
type of nephropathy with accumulation of subepithelial and/or subendothelial 
immune deposits (11), or cause an anti-basement membrane type of glomerular 
disease with uniform binding of antibodies in a linear pattern to the GBM (12). 
We report here our pathophysiologic, light microscopic, and electron microscopic 
findings  indicating  that  binding  of  anti-HSPG(GBM)  IgG  induces  an  anti- 
basement membrane type of disease with proteinuria and subepithelial basement 
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membrane thickening.  An  abstract  describing  these  results has also been  pub- 
lished (13). 
Materials and  Methods 
Anti-Heparan Sulfate Proteoglycan Antibodies.  Rabbit anti-HSPG(GBM) was character- 
ized  in  detail  elsewhere  (8).  In  brief,  the  antiserum  was  raised  against  proteoglycans 
purified  from  isolated  rat  glomeruli  by  ion  exchange  chromatography.  It  specifically 
recognizes the core protein of the Mr =  130,000  basement membrane HSPG, does not 
show  crossreactivity  with  laminin,  type  IV  collagen,  or  fibronectin  by  ELISA,  and 
selectively stains all basement membranes in rat kidney and other tissues by immunoflu- 
orescence and immunoperoxidase techniques (8). Rabbit antibodies against the Heymann 
nephritis antigen (gp330) (14) and a normal rabbit serum pool were used as controls. 
IgG fractions were isolated from the rabbit sera by affinity chromatography on protein 
A-Sepharose CL-4B (Pharmacia Fine Chemicals, Piscataway, N  J), and the IgG content of 
the fractions was determined by measuring the OD at 280  nm.  The anti-HSPG(GBM) 
antiserum was absorbed with rat blood cells before isolation of IgG to remove crossreacting 
antibodies (15). 
Experimental  Protocol.  Male  Sprague-Dawley  rats  (Camm  Research  Lab  Animals, 
Wayne, N  J, or Charles River Breeding Laboratories, Inc., Wilmington,  MA), weighing 
150-200  g,  were  injected  intravenously  via  the  external  jugular  vein  with  anti- 
HSPG(GBM) IgG (3-20 rag), or anti-gp330 IgG (5 rag), or normal rabbit IgG (21  rag) in 
1 ml of PBS, pH 7.2.  22 rats received anti-HSPG(GBM) IgG, 6 rats received anti-gp330 
IgG, and 3 rats received normal rabbit IgG. 
Serum and urine samples were collected from experimental rats and from age-matched 
controls before, and at regular intervals of 3 min to 2 mo after, injection of rabbit IgG. 
Anti-HSPG(GBM) that  had  been  preabsorbed with  rat  blood ceils  (15)  was  tolerated 
without incidence; the injected rats appeared normal during the 2-too observation period, 
and no gross abnormalities were detected in their kidneys. If native (unabsorbed) IgG was 
given, some of the rats developed anaphylactic symptoms (respiratory distress), and one 
rat injected with 20 mg of IgG died immediately after injection. 
Preparation  and  Processing  of  Tissues for  Immunocytochemistry  and  Electron  Micros- 
copy.  Tissue  blocks  were  taken  from  the  right  kidneys,  livers,  spleens,  and  lungs  of 
normal and experimental rats, snap frozen in isopentane cooled with liquid nitrogen, and 
stored in  liquid  nitrogen.  Cryostat sections (5 ~m) were prepared from unfixed tissues, 
mounted on glass slides,  fixed in acetone for 10 min at -20°C, and used for immunoflu- 
orescence staining. 
The  left  kidney  was  flushed  with  PBS  and  fixed  by  retrograde  perfusion  via  the 
abdominal  aorta  with  a  2%  solution  of paraformaldehyde  freshly  made  in  a  sodium 
phosphate buffer (0.04 M) containing lysine (0.08 M) and sodium metaperiodate (0.01 M) 
(16), after which tissue pieces were prepared and immersed in this fixative (PLP) for an 
additional 4 h at 20 ° C. Some of the tissue pieces were cryoprotected by incubation in 2.3 
M  sucrose,  frozen in  liquid  nitrogen,  and  sectioned at 0.5  ~m on a  Reichert  UItracut 
ultramicrotome (Reichert Scientific Instruments, Buffalo, NY) equipped with cryo-attach- 
ment using the techniques of Tokuyasu et al.  (17).  These semithin sections were then 
mounted on poly-L-lysine-coated slides and used for immunofluorescence. Other pieces 
of aldehyde-fixed kidney tissue were washed in PBS for  10 min, cryoprotected in  10% 
DMSO,  snap  frozen,  and  stored  in  liquid  nitrogen  until  used  for immunoperoxidase 
Iocalizations as described below. 
Tissue  blocks  were  taken  from  both  kidneys,  immersed  in  1%  glutaraldehyde/4% 
formaldehyde in 0.1  M sodium cacodylate buffer for 1 h at 20°C  or overnight at 4°C, 
postfixed in  veronal acetate-buffered  OsO4, stained  in  block with  uranyl acetate, and 
dehydrated and embedded in Epon for electron microscopy. 
Localization  of Basement  Membrane  HSPG  in  Rat  Kidney  by  Indirect  lmmunofluores- 
cence.  Acetone-fixed  cryostat  sections  (5  ~m)  or  semithin  frozen  sections  (0.5  ~m) 
prepared from aldehyde-fixed tissue were incubated for 30 rain to 2 h at 20°C with the 1066  GLOMERULAR  CHANGES  INDUCED  BY  PROTEOGLYCAN  ANTIBODIES 
anti-HSPG(GBM)  IgG.  After  washing  in  PBS  for  10  min,  they  were  incubated  with 
rhodamine-labeled goat anti-rabbit IgG (Cappel Laboratories, Cochranville, PA) for 30 
rain,  washed  again  in  PBS,  mounted  in  PBS-glycerol,  pH  7.2,  and  examined  in  a 
photomicroscope III (Carl Zeiss, Inc., Thornwood, NY) equipped with phase contrast and 
epifluorescence optics and appropriate filters for rhodamine and fluorescein. 
Detection of Anti-HSPG(GBM) IgG, Rat IgG, and C3 in Rat Tissues by Direct lmmunofluo- 
rescence.  Cryostat sections were incubated with either rhodamine-labeled goat anti-rabbit 
IgG,  fluorescein-labeled  rabbit  anti-rat  IgG,  or  fluorescein-labeled  goat  anti-rat  C3 
antibodies (Cappel Laboratories) for 30 min at 20°C, washed in PBS, mounted with PBS- 
glycerol, and studied by immunofluorescence microscopy. 
lmmunoperoxidase  Staining Procedures.  Cryostat sections (20-30  #m) were prepared 
from PLP-fixed kidney tissues and stained by a direct immunoperoxidase technique based 
on  an  indirect  immunoperoxidase  procedure  previously  described  (18).  Briefly,  the 
sections were incubated for 2 h at 25°C with either Fab fragments of sheep anti-rabbit 
IgG conjugated to horseradish peroxidase (HRP) (Biosys,  Paris, France) to detect rabbit 
IgG, or with a sheep anti-rat C3 conjugated to HRP (Cappel Laboratories) to detect rat 
C3 bound to glomeruli. The sections were then fixed in  1.5%  glutaraldehyde, incubated 
in diaminobenzidine medium containing 0.005% H~O2, postfixed in ferrocyanide-reduced 
OsO4, and dehydrated and embedded in epoxy resin for electron microscopy. Ultrathin 
sections were prepared, stained with uranyl acetate and lead citrate, and examined in a 
Philips 301  electron microscope operating at 60 kV. 
Counts of Leukocytes Adhering to Glomeruli.  The number of polymorphonuclear leuko- 
cytes (PMN) per giomerulus was counted on semithin (0.5 #m) sections cut from Epon- 
embedded cryostat sections of rat kidney stained for rabbit IgG by the direct immuno- 
peroxidase technique.  At least three different glomeruli were counted from each kidney 
by phase  contrast  microscopy.  Since  the  kidneys  were  perfused  free  of blood  before 
fixation, only those leukocytes adhering to glomerular components remained. 
Detection of Rabbit Antibodies  in Rat Sera.  Disappearance of the injected rabbit anti- 
HSPG(GBM) and anti-gp330 IgG from rat sera was monitored by an indirect immunoflu- 
orescence assay. Serial dilutions of serum samples obtained from 15 to 2 mo after antibody 
injection were applied to unfixed cryostat sections (5 #m) of normal rat kidney for 30 
min.  After washing in  PBS  the  sections were  incubated  with  rhodamine-labeled anti- 
rabbit IgG (Cappel Laboratories), washed again, and mounted for immunofluorescence 
microscopy. The staining of basement membranes or proximal tubular brush borders at 
serial  dilutions  was  determined  and  used  to  assess  the  amounts  of  circulating  anti- 
HSPG(GBM) or anti-gp330 IgG, respectively, remaining in the circulation. Rat sera were 
screened for the presence of anti-GBM autoantibodies by a similar immunofluorescence 
assay using fluorescein-labeled anti-rat IgG (Cappel Laboratories) as the second antibody. 
Detection of Anti-Rabbit lgG in Rat Sera.  The appearance of antibodies against rabbit 
IgG in the sera of rats injected with rabbit IgG was determined  using double immuno- 
diffusion in  1%  agarose and an ELISA. For double diffusion,  undiluted  rat sera were 
reacted  against  normal  rabbit  IgG (1  mg/ml of PBS).  For  the  ELISA,  flat-bottomed 
microtiter wells  (Nunc-immunoplate  I  F,  Gibco Laboratories, Grand Island,  NY) were 
coated with normal rabbit IgG (2.5 ~g/ml), washed with PBS containing 0.05% Triton X- 
100, and quenched with 0.4% of BSA. They were then incubated with rat sera diluted in 
the same buffer followed by affinity-purified HRP-labeled goat anti-rat IgG (Kirkegaard 
&  Perry  Laboratories,  Inc.,  Gaithersburg,  MD)  and  orthophenylenediamine  substrate 
(Sigma Chemical Co., St.  Louis, MO), and absorbance was read on a Titertek Multiskan 
microplate  reader  (Flow  Laboratories,  Inc.,  McLean,  VA)  (19).  The  conjugate  was 
preabsorbed against rabbit IgG. 
Measurement of Urinary Albumin.  Urine samples were collected, usually for a period of 
18 h, from rats kept individually in metabolic cages; they had free access to water. Samples 
were centrifuged in a table top centrifuge and stored at -20 ° until albumin was measured 
by radial immunodiffusion in  1% agarose prepared in 0.2  M phosphate buffer, pH 8.4 
(20),  containing  rabbit  anti-rat  albumin  antibodies  (Cappel  Laboratories).  Rat  serum M1ETTINEN  ET  AL.  1067 
FIGURE  I.  Fluorescence micrographs ofsemithin (0.5 #m) frozen sections ofperfusion-fixed 
rat  kidneys.  (A)  Section from a  normal  rat  kidney stained  by indirect immunofluorescence 
with anti-HSPG(GBM).  The antibody stains all renal  basement  membranes,  i.e., the  GBM, 
Bowman's  capsule,  the  basement  membranes  of renal  tubules,  and  those  of peritubular 
capillaries.  (B)  Direct  immunofluorescence  staining  of  the  kidney  of a  rat  at  2  h  after 
intravenous injection of anti-HSPG(GBM) IgG. The antibody binds only to the GBM. ×  250. 
albumin (Sigma Chemical Co.) was used as a standard. For statistical analysis the Student's 
t test was used. 
Quantitation of lgG Binding to Rat Tissues.  Anti-HSPG(GBM) and normal rabbit  IgG 
were radiolabeled with ~5I (Carrier free; Amersham Corp., Arlington Heights, IL) using 
Iodo-Beads (21) (Pierce Chemical Co.,  Rockford,  IL) according  to the manufacturer's 
instructions. The specific activities of the labeled antibodies varied from 0.8 to 2 uCi/ug 
IgG.  ~25I-Anti-HSPG(GBM) IgG (130-220  ~g) or ~25I-normal rabbit  IgG (30-100 t~g) 
were injected  intravenously  into three rats  each, as described  above.  After 1-2 h  the 
animals were perfused via the abdominal aorta with PBS, and the kidneys, lungs, livers, 
and spleens were removed, weighed, and counted for l~sI. Glomeruli were prepared (22) 
from the kidneys of the rats killed 1 h postinjection and counted for bound ~5I. 
Results 
Localization  of Basement  Membrane  HSPG  in  Normal  Rat Kidney  by  Indirect 
Immunofluorescence.  As  reported  previously  (8),  when  the  rabbit  anti- 
HSPG(GBM) IgG was used to stain kidney sections by indirect immunofluores- 
cence,  it  reacted  with  all  renal  basement  membranes:  the  GBM,  Bowman's 
capsule, and all  tubular and  vascular basement membranes (Fig.  1A).  Rabbit 
antibodies against gp330, the pathogenic antigen of Heymann nephritis, bound 
to the brush borders of renal proximal tubules and gave a faint granular staining 
of glomeruli (22).  Normal rabbit IgG did not stain any kidney structure. 
Rapid Depletion of Anti-HSPG(GBM)  IgG from Rat Blood.  15 min after intra- 
venous injection of 5 mg of anti-HSPG(GBM) IgG, the injected IgG was detected 
in rat sera at a  1:1,000 dilution by the indirect immunofluorescence assay, at 2 
h it was detected only in undiluted sera, and at 1 d none was found. These results 
show that the anti-HSPG(GBM) IgG rapidly disappeared from the sera of the 
injected rats.  By contrast the anti-gp330 IgG disappeared only slowly from the 
circulation; at  15  min it was detected at a dilution of 1:100, after  1 d  at  1:10, 
and at 2 wk was still detected in undiluted sera. 
Anti-HSPG(GBM) Binds Rapidly  to the Laminae Rarae of the GBM.  As early as 
3  min  after  intravenous  injection  of anti-HSPG(GBM)  IgG,  rabbit  IgG  was 
detected by light microscopy (Figs.  1 B and 2A) as linear deposits outlining the 1068  GLOMERULAR  CHANGES  INDUCED  BY  PROTEOGLYCAN  ANTIBODIES 
FIGURE 2.  Immunofluorescence micrographs showing anti-HSPG(GBM) IgG (A-C), rat C3 
(D and E), and rat IgG (F) bound to glomeruli in kidneys of rats injected with anti-HSPG(GBM) 
IgG. After intravenous injection, bright linear deposits of rabbit IgG are present in glomerular 
capillaries at all intervals, i.e., 15 min (A), 4 d (B), or 2 mo (C) postinjection. Linear deposits 
of C3 are also seen along the  GBM at 2 h postinjection (D), but could not be detected  in 
glomeruli after 4  d  (E). C3  was seen  along  tubular  basement  membranes  and  Bowman's 
capsule (D and E) in all the injected animals, including normal controls. From  1 wk to 2 mo, 
linear deposits of rat IgG could be detected in the glomeruli of some of the rats injected with 
anti-HSPG(GBM) IgG (F). G, glomerulus; T, tubule, x 450. 
capillary walls  of all  glomeruli.  This staining  pattern  suggested  that  the  rabbit 
IgG was bound  to the  GBM.  The staining intensity  increased  up to  2  h  postin- 
jection  but  thereafter  remained  virtually  unchanged  during  the  entire  2-mo 
observation  period  (Fig.  2,  B  and  C,  Fig.  3A;  Table  I).  There  was  little  or  no 
binding  of rabbit  IgG to any other  renal  structure  except  for occasional  areas 
where  there was binding to the basement membranes of peritubular  capillaries 
and those of the adjacent tubules (Fig.  3B). Such sites were found in 4  of the  14 
rats injected  with  small amounts (3-5  mg) and in all of the  6  rats injected  with 
larger amounts (12-20  mg) of anti-HSPG(GBM) IgG. Presumably this occurred 
due to local leakage ofanti-HSPG(GBM) IgG from peritubular capillaries. Rabbit 
IgG was never detected  in  Bowman's capsule or in the  walls of renal arterioles 
in any of the injected rats. 
When the bound anti-HSPG(GBM) IgG was localized by direct immunoperox- 
idase staining at the electron microscope level, it was seen as early as 3 min after MIETTINEN  ET AL.  1069 
FIGURE  3.  Phase contrast micrographs of semithin (0.5  ttm)  sections cut from  Epon-em- 
bedded cryostat sections of rat kidney stained for rabbit IgG by the direct immunoperoxidase 
technique. Sample taken from a rat given anti-HSPG(GBM) IgG  15 min before killing. (A) 
Rabbit lgG is deposited along the GBM and in mesangial areas. Several PMN leukocytes are 
present in the lumen of the glomerular capillaries (arrows). The PMN can be identified by 
their dense granules, which stain with the diaminobenzidine reagent due to their endogenous 
myeloperoxidase  activity. (B) In some areas, rabbit IgG is detected in the basement membranes 
of a peritubular capillary and the immediately adjacent tubules (arrows). × 800. 
TABLE  I 
Imraunofluorescence  Findings in Kidneys of Rats after Intravenous Injection  of Anti- 
HSPG(GBM) 
Number  Amount of  Linear GBM deposits*  Time 
postinjection  of rats  IgG injected 
injected  (rag)  Rabbit IgG  Rat C3  Rat IgG 
3 min to 1 d  7  3-5  ++ (7/7)*  ++ (6/6)  -  (0/6) 
4 d  3  5-12  +++ (3/3)  +  (2/3)  -  (0/3) 
1-3 wk  6  3-20  +++ (6/6)*  +  (1/5)  + (4/5) 
4-8 wk  6  5-20  +++ (6/6)  + (4/6)  + (6/6) 
Semithin (0.5  ttm) or cryostat (5 ttm) sections of rat kidneys were incubated with fluorochrome- 
labeled antibodies against rabbit IgG, rat C3, and rat IgG. 
* +++, ++, +, _+, and -  indicate very strong, strong, moderate, weak, and negative fluorescence 
after direct staining. Numbers in parentheses indicate number of samples positive per number of 
samples studied. 
* Includes a semithin section of a plastic-embedded cryostat section stained for rabbit IgG by the 
direct immunoperoxidase technique. 
injection in the GBM and the mesangial matrix (Fig. 4). Within the GBM, binding 
occurred largely or exclusively to both laminae rarae, interna and externa, giving 
the GBM a  tram-track appearance (Fig. 5, A and B). Little or no reaction product 
was  seen  in  the  lamina densa.  At early intervals (3  min  to  4  d),  staining of the 
lamina rara interna (LRI) was somewhat  more extensive than that of the lamina 
rara  externa  (LRE),  whereas  at  later intervals (4  d  to  1  mo)  the  situation  was 
reversed,  and  binding  to  the  LRE  predominated.  Staining  of  the  mesangial 
matrix  was  most  extensive  at  1  d  postinjection,  after  which  it gradually disap- 
peared. 
In  controls  injected  with  anti-gp330  IgG,  the  staining  pattern  was  quite 1070  (;LOMERULAR  CHANGES  INDUCED  BY  PROTEOGLYCAN  ANTIBODIES 
FIGURE 4.  Electron  micrograph of a field from the glomerulus of a rat injected  with 20 mg 
anti-HSPG(GBM)  lgG,  1 d  before  killing. The  section  was prepared  from aldehyde-fixed 
kidney  tissue, which  has been  stained  by direct  immunoperoxidase  to localize rabbit  lgG. 
Reaction  product indicating  the sites of deposited  lgG, is detected in the mesangial matrix 
(arrows) and in the GBM (BM) where it is concentrated in the laminae  rarae.  There is no 
staining of the endothelial  (En), epithelial (Ep), or mesangial (Me) cells. Cap, capillary lumen. 
x  10,000. 
different from that obtained with anti-HSPG(GBM)  IgG, and binding to glomer- 
uli  increased  gradually  with  time;  at  15  min  postinjection  a  faint  granular 
fluorescence was seen along the glomerular capillary walls which became increas- 
ingly more intense  by 2  h, and the size of the granular  deposits increased  up to 
3  wk.  In controls  injected  with  21  mg of normal  rabbit  IgG, a  faint glomerular 
and interstitial  staining for rabbit  IgG was seen  in rat kidneys 2  h  after  injection MIETTINEN  ET  AL.  1071 
FIGURE 5.  Preparations similar to that in Fig. 4, from a rat killed 1 d (A) and 2 h (B) after 
injection of anti-HSPG(GBM) IgG. At higher magnification the bound rabbit IgG is seen to 
be concentrated in the lamina rara interna (LRI) and lamina rara externa (LRE) of the GBM, 
giving the GBM a  tram-track appearance. By contrast, there is little or no staining of the 
lamina densa (LD) in either field. The lumen of the capillary in A contains a mononuclear cell 
(MC), believed from its morphology to be a lymphocyte, and the lumen of the capillary shown 
in B contains a  PMN, identified by its multilobed nucleus (nu) and characteristic specific (sg) 
and azurophil (ag) granules. Both cells can be seen to extend multiple pseudopods (arrows) 
through the endothelial fenestrae to directly contact the LRI of the GBM where the rabbit 
IgG and rat C3 (see Fig. 6) are deposited, x  26,000. 1072  GLOMERULAR CHANGES  INDUCED  BY  PROTEOGLYCAN  ANTIBODIES 
TABLE II 
Distribution of Radioactivity after Injection of lz5i_labele  d Anti- 
HSPG(GBM) lgG in Rats 
Organs* 
Percent injected radioactivity  bound per 
gram tissue 
Anti-HSPG(GBM)  Normal rabbit IgG 
Kidneys  (6)  0.63 _+ 0.20*  0.27 _+ 0.17 
Lungs (3)  0.58 _+ 0.25  0.46 _ 0.11 
Livers (3)  0.36 +_ 0.16  0.31 _ 0.09 
Spleens (3)  0.47 ___ 0.26  0.27 _ 0.12 
130-220 t~g of ~51-1abeled anti-HSPG(GBM) or 30-100 ~g ~51-1abeled 
normal rabbit  IgG were injected intravenously. !  or  2 h later, the 
animals were killed, perfused via the abdominal aorta, and the organs 
were weighed and counted for radioactivity. 
* Numbers in parentheses indicate the number of organs counted. 
* Significantly increased binding of anti-HSPG(GBM) IgG as compared 
with normal rabbit IgG (p < 0.01) was found only in kidney tissue. 
but was not detectable thereafter. By immunoperoxidase staining only subepi- 
thelial deposits of rabbit IgG were seen in the glomeruli of the rats injected with 
anti-gp330 IgG. No rabbit IgG was detected in control rats injected with normal 
rat IgG. 
Binding  of Injected  Anti-HSPG(GBM)  to  Other  Organs.  The  injected  anti- 
HSPG(GBM)  IgG  was  also  detected by  immunofluorescence in  the  liver  and 
spleen  where  it  was  seen  in  the walls of blood  vessels and,  in  the  case of the 
spleen,  in the extracellular matrix of the red pulp and at the periphery of the 
white pulp (data not shown). 
Quantitation of the Bound Anti-HSPG(GBM) IgG.  When 12~I-anti-HSPG(GBM) 
IgG was injected into rats and the amount of IgG bound was compared with that 
of rats given normal rabbit IgG, only in the kidney was the amount bound per 
gram of tissue significantly increased over controls (Table II). When the glomer- 
uli were  isolated, and the amounts of labeled  IgG bound were  compared  1 h 
after injection, about 100 times more IgG was bound to glomeruli of rats given 
anti-HSPG(GBM) IgG than to those given normal rabbit IgG. This indicates, in 
confirmation of the immunofluorescence findings, that most of the specific IgG 
was bound to glomeruli. After injection of 130-220 #g of ~25I-anti-HSPG(GBM) 
IgG, ~0.36%  of the IgG was specifically bound per gram  kidney tissue (Table 
II).  Assuming that  the  same  percentage  of total  IgG  given  would bind  after 
injection of 3, 5, 12, and 20 mg of unlabeled anti-HSPG(GBM) IgG, we estimate 
that -1 1,  18, 43, and 72 t~g were bound per gram kidney, respectively. 
Liver, spleen, and lung bound slightly more  125I-anti-HSPG(GBM) IgG than 
normal rabbit  IgG, but the differences were  not statistically significant (Table 
I I). It can be concluded that immunofluorescence gives a more precise indication 
of the sites of deposition of specific IgG than do measurements of radioactivity 
because of the high background of radiolabeled nonspecific IgG. 
Rat C3 Binds Exclusively  to the LRL  By immunofluorescence, linear deposits 
of rat C3  were seen along the capillary walls of all glomeruli as early as 3  min 
after injection ofanti-HSPG(GBM) IgG (Table I). The amount present increased MIETTINEN  ET  AL.  1073 
up to 2 h  postinjection (Fig.  2D) but thereafter decreased rapidly, and C3 was 
no  longer  detectable  in  glomeruli  at  4  d  postinjection  (Fig.  2E).  From  1 wk 
postinjection on, deposits of C3 reappeared in the glomeruli of some of the rats 
(Table I).  This occurred at the same time as rat antibodies against rabbit IgG 
appeared in the sera (see below) and linear deposits of rat IgG were first found 
in glomeruli of the injected rats (Fig. 2F; Table I). No binding of C3 to glomeruli 
was detected  after  injection  of normal  rabbit  IgG.  However,  as  reported  by 
others (23), all rats, controls included, showed deposits of C3 along some tubular 
basement membranes (Fig. 2, D and E). 
When  C3  was localized at  the  electron  microscope level by direct  immuno- 
peroxidase staining,  at 3 min to 1 d  it was seen to be bound to the GBM where 
it was confined exclusively to the LRI and to the mesangial  matrix (Fig. 6). No 
staining of the lamina densa or LRE was seen. At 4 d, C3 was no longer detected 
in  the  LRI, but at  2  wk postinjection staining  of the  LRI reappeared  in  some 
glomeruli, in keeping with the immunofluorescence results. 
Early  Morphological Changes Induced  in  the  LRI  by  Binding  of Anti-HSPG 
GBM.  In the early stages (15  min  to 4  d) after injection  of anti-(HSPG)  IgG, 
the only morphological changes detected in the GBM were confined to the LRI; 
periodic,  flocculent subendothelial  deposits of moderate electron density were 
visible in routine morphoiogic preparations, and there appeared to be a general 
distention  of the  LRI (Fig.  7).  The  location of the deposits in  the  LRI corre- 
sponded to the sites of deposition of rabbit IgG and C3. A lifting or swelling of 
fenestrated portions of the endothelial cytoplasm was also evident in some places 
(Fig.  7).  By 4  d  these deposits were no longer visible and  the swelling was no 
longer evident. Thus, the presence of morphologically recognizable, moderately 
dense deposits corresponded closely in time and location to that of rat C3. 
Adherence of Leukocytes to the GBM.  Increased numbers of mononuclear (Figs. 
5A and  6) and  PMN (Figs.  3A and  5B) leukocytes were seen adhering  to the 
walls of many glomerular capillaries at intervals of 3 min to 4 d  after injection 
of the  anti-HSPG(GBM)  IgG.  They  were  often  seen  to  extend  pseudopods 
through the endothelial fenestrae to come into direct contact with the LRI (Figs. 
5 and 6) where the rabbit IgG and the rat C3 deposits were located. The identity 
of the mononuclear cells could not be determined with certainty, but those that 
adhered during the first 4 d postinjection (Figs. 5A and 6) resembled lymphocytes 
in their morphology (rounded nuclei, high nuclear/cytoplasmic ratio), and those 
that bound at later times (1 wk to 2 mo) resembled more monocytes (crescentic 
nuclei, more abundant cytoplasm). 
When  PMN were counted by phase contrast microscopy in semithin  sections 
(Fig.  3A),  their  number  was found  to  be increased  at  all  intervals  up to  1 d 
postinjection. The average number of PMN per glomerulus at 8 min,  15 min,  2 
h,  and  1 d  postinjection  was  1.5,  4.5,  1.8, and  1.4,  respectively. After 4  d  the 
number decreased (0-0.8) and was comparable to that found in controls injected 
with  normal  rabbit  IgG (0-0.3).  The  number  of mononuclear  leukocytes was 
not quantitated because they could not be distinguished from resident glomerular 
cells by light microscopy. 
Induction of Anti-Rabbit IgG.  Antibodies against rabbit IgG were detected in 
the sera of most rats after  1 wk postinjection. 9 out of the  11  anti-HSPG(GBM) 1074  GLOMERULAR  CHANGES  INDUCED  BY  PROTEOGLYCAN  ANTIBODIES 
FIGURE 6.  Field from a section prepared from the kidney of  a rat killed 15 min after injection 
ofanti-HSPG(GBM) IgG, which has been stained by direct immunoperoxidase  for the presence 
of rat C3. C3 is found in the GBM and mesangial matrix (MM). It is localized exclusively in 
the LRI  (LRI) of the GBM.  A  circulating cell, believed to be a  lymphocyte (L),  is seen to 
extend a pseudopod through an endothelial fenestra (arrow)  to contact the LRI of the GBM. 
x  14,000. 
IgG-injected rats tested, and 2  out of the 4  controls injected with either anti- 
gp330  or normal rabbit  IgG tested showed circulating antibodies with varying 
titers (1 : 10 to 1  : 1,000) by ELISA. No direct relationship between antibody titers 
and amount ofalbuminuria (see below) was apparent, and precipitating antibodies 
were not seen in the immunodiffusion assay. 
No  autoantibodies against the GBM  or  other  kidney basement membranes 
were detected in the sera of rats injected with anti-HSPG(GBM) IgG by indirect 
intmunofluorescence. 
Induction of Subepithelial Basement Membrane Thickening.  As early as 9 d after 
injection of anti-HSPG(GBM) IgG some thickening and distortion of the GBM M1ETTINEN  ET  AL.  1075 
FIGURE 7.  GBM from a rat injected with 5 mg anti-HSPG(GBM) 15 min before killing. The 
section was prepared from aldehyde-fixed kidney tissue which had been stained in block with 
uranyl acetate, and processed for routine morphology.  Punctate electron-dense deposits are 
seen in the LRI (arrows).  They correspond in their location to that of the immune deposits 
containing C3  (see Fig.  6). The LRI appears broadened and distended, displacing the endo- 
thelium (En) in places, while the LRE and lamina densa of the GBM appear normal, x  30,000. 
was noted, which varied in extent from loop to loop (Fig. 8). The GBM thickening 
was more prominent in rats that received 20 mg of IgG than in those that were 
given only 5  mg.  It became progressively more severe with time, and by 2  mo 
postinjection some areas of the GBM were two to three times their normal width, 
and the outer aspect of the GBM often had a scalloped appearance (Figs. 8 and 
9). 
In specimens prepared  for routine morphology,  several morphologically dis- 
tinct layers of basement membrane-like material could often be detected in the 
thickest regions of the GBM (Fig,  8B).  In sections stained for rabbit  IgG (Fig. 
9), it was clearly seen that tile thickening  and scalloped appearance was due to 
the addition of an uneven layer of material with a density comparable to that of 
the lamina densa on the epithelial side of the original GBM, which displaced the 
bound  IgG  toward  the  endothelium  (Fig.  9,  B  and  C).  In  some  regions  the 
original LRI and LRE could still be detected (by virtue of the bound IgG) in the 
thickened  basement membrane  (Fig.  9B),  but in others only the residual  LRE 
and  lamina densa were visible (Fig.  9C),  suggesting that the IgG bound to the 
LRI (Fig. 9A) had been removed from the endothelial side or denatured. 
No thickening of the GBM was observed at any interval (up to 2  too) in age- 
matched controls given 20 mg of normal rabbit IgG. 
Increased Urinary Excretion of  Albumin.  The binding of anti-HSPG(GBM) IgG 
to  the  GBM  caused  a  moderate  but  significant  increase  in  urinary  albumin 
excretion (Fig.  10) that was clearly dose dependent.  The mean albuminuria  of 
rats injected with  12 mg of anti-HSPG(GBM) IgG or more was 1.2 (range 0.1  to 
3.2) rag/24  h  in the first  1-5 d  after injection of rabbit  IgG, and increased to 
12.0 (range 6.6 to 17.2) mg/24 h by 2 mo postinjection. The mean excretion of 
albumin  of 1- and  3-mo-old control  rats were 0.4 (range  0.04  to  1.7) and  0.7 
(range 0.2 to 1.9) rag/24 h, respectively. These results show that the binding of 1076  GLOMERULAR  CHANGES  INDUCED  BY  PROTEOGLYCAN  ANTIBODIES 
FIGURE 8.  Preparations similar to those in Fig. 7. (A) Shows widespread, irregular thickening 
of the GBM in the glomerulus of a rat killed 19 d after injection of 20 mg of anti-HSPG(GBM) 
IgG. The thickening is marked in some portions of the capillary loops (arrows)  and is minimal 
in others. (B) Higher magnification view of a  region of thickened GBM.  Several successive 
layers of basement membrane-like material can be detected in the thickened areas (arrows). 
(A) x  12,000; (B) ×  26,000. MlETTINEN  ET  AL.  1077 
FIGURE 9.  Localization of rabbit IgG in the GBM of rats at various times after injection of 
20 mg of anti-HSPG IgG. (A) 2 h postinjection. Rabbit IgG is concentrated in the lamina rara 
interna (LRI) and externa (LRE) of the GBM, with little or no staining of the lamina densa 
(LD).  (B and C) 2  mo postinjection. Rabbit IgG is still  present in the GBM and deposits of 
basement membrane-like material are seen on  the epithelial side of the GBM,  giving it a 
scalloped appearance. The new layer of basement membrane is only weakly reactive (B) or 
unreactive (C) for bound IgG (short arrows). In some areas, the original laminae rarae (LRI, 
LRE) can be detected (B), but in other areas (C) the stained LRI has disappeared, leaving only 
the former LRE that can be recognized because it stains for rabbit IgG (long arrows, B). (A) X 
26,000; (B) x  50,000; (C) x  32,000. 1078  GLOMERULAR  CHANGES INDUCED BY  PROTEOGLYCAN ANTIBODIES 
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FIGURE 10.  Histogram  showing the dose-dependent increase in the  urinary excretion of 
albumin caused by the binding of anti-HSPG(GBM) IgG to rat glomeruli. Stipled bars, mean 
albuminuria of rats injected with 3-5 mg anti-HSPG(GBM) IgG. Hatched bars, mean albu- 
minuria of rats given 12-20 mg of anti-HSPG(GBM) IgG. Open bars, age-matched control 
rats. A statistically  significant  increase (marked by an asterisk) compared with controls is seen 
at all periods after injection of the higher dose (p < 0.001), and at l-2 mo after injection of 
the lower dose (marked by a dot) (p < 0.05). N, the number of urine samples studied. 
anti-HSPG(GBM)  IgG  caused  an  increase  in  the  permeability of the  GBM  to 
albumin. 
Discussion 
From  the  pathophysiologic,  immunofluorescence, and  electron  microscopic 
results we  can  reconstruct  the following sequence  of events that occurs  when 
antibodies specific for the core proteins of basement membrane  HSPG  (M~ = 
130,000) are injected into rats. The injected IgG binds immediately (by 3 rain) 
to matrix elements in several organs (kidney, liver, spleen) and is rapidly depleted 
from  the  circulation.  In  the  kidney, the  antibody binds  almost exclusively to 
laminae rarae  of the  GBM  where  the  HSPG antigen  is  located  (8).  Although 
these  HSPG  are  present  in  all  renal  basement  membranes  (8),  the  anti- 
HSPG(GBM) IgG binds only to the GBM where the structure of the endothelium 
with its open fenestrae (lacking diaphragms) allows direct access of the circulating 
IgG to the GBM. Presumably, the antibodies do not bind as readily to basement 
membranes of peritubular  capillaries because the endothelium of these vessels 
has fenestrae and transendothelial channels with diaphragms (24) which undoubt- 
edly retard transport.  Also, the bulk of the antibody may be cleared from the 
renal circulation by binding to the GBM before reaching these capillaries. The 
binding of rabbit IgG along the subendothelial surface of the GBM immediately 
(by 3 min) activates complement, which is deposited exclusively in the LRI and 
attracts mononuclear and PMN leukocytes to the glomeruli. These cells adhere 
to the capillary wall and project pseudopods through the endothelial fenestrae 
to contact the immune complexes in the LRI. After 4 d, the number of attracted 
leukocytes decreases and C3 is no longer detectable, suggesting that these cells 
may be responsible for the removal or denaturation of C3. However, the injected 
anti-HSPG(GBM) IgG remains firmly bound to the laminae rarae and is detect- 
able for long periods (up to 2 mo). The binding of anti-HSPG(GBM) IgG to its MIETTINEN  ET  AL.  1079 
antigen concentrated in the laminae rarae results in a dose-dependent, progres- 
sive thickening of the GBM which is due to the laying down of a new basement 
membrane layer beneath the glomerular epithelium. 
The overall response to the injected anti-HSPG(GBM) lgG, i.e., binding in a 
linear pattern to the GBM, C3 deposition, leukocyte infiltration, and proteinuria, 
is typical of the acute phase  of "nephrotoxic," anti-GBM  nephritis (12)  but  is 
quite different from that found in Heymann nephritis, an experimental model 
of membranous glomerulonephritis (11). It is also similar to the response seen in 
rats  or  mice given  antibodies prepared against  purified basement  membrane 
components, such as laminin (23, 25, 26), and type IV collagen (25, 26), except 
that proteinuria was not detected in the acute phase after injection of the latter 
antibodies. The proteinuria induced by anti-HSPG(GBM) IgG was clearly dose- 
dependent since it appeared early (during the first 5  d) only in  those animals 
given  12-20  mg,  and  it  increased with  time but  was still  modest after  2  mo 
compared  with  that  seen  in  classical  anti-GBM  nephritis  (27).  In  fact,  the 
pathologic and pathophysiologic consequences of injecting anti-HSPG(GBM) IgG 
were less severe than those induced by anti-GBM antibodies. The milder nature 
of the response cannot be explained on the basis of the amount of IgG given, 
because the amount of anti-HSPG(GBM)  IgG  we estimate to  be bound after 
injection of 20 mg (72 ~g/g kidney) is similar to the amount of bound anti-GBM 
IgG (75/~g/g) required to induce severe proteinuria (27). The milder nature of 
the response may be explained by the fact that one is dealing with a monospecific 
antibody rather than an antibody mixture. The traditional nephrotoxic antibod- 
ies have been prepared using whole cortical homogenates, whole glomeruli, or 
crude GBM preparations as immunogens, and undoubtedly recognize multiple 
glomerular antigens. 
It should be mentioned that patients with anti-GBM glomerulonephritis have 
circulating antibodies against noncollagenous and collagenous components of the 
GBM  (28-30),  and autoantibodies against the nonhelical carboxyterminal do- 
main (NC-1) of type IV collagen have been implicated as the causative factor 
(31, 32) in Goodpasture's syndrome, a rapidly progressive form of the disease. 
So far, however, it has not been possible to produce an equally severe disease in 
experimental animals given antibodies against type IV collagen (25, 26). It can 
be concluded that, in all likelihood, factors such as species differences and the 
specificity  and  amount  of anti-GBM  antibodies  given  may  affect  the  renal 
response. 
Several of the present findings are novel or noteworthy: (a) This is the first 
situation  in which antibodies raised against a  basement membrane component 
were found to bind exclusively to the laminae rarae of the GBM.  In anti-GBM 
disease (33-35),  or after injection of anti-type IV collagen (36) or anti-]aminin 
IgG (23, 36), or antibodies raised against another (Mr =  400,000) population of 
HSPG isolated from the EHS sarcoma (36),  the antibodies bound to all three 
layers of the GBM; (b) we showed that C3 bound only to the LRI, and to our 
knowledge, this is the first example of selective binding of C3  to the LRI.  C3 
has not been localized previously at the EM  level in anti-GBM disease, and in 
immune complex disease (induced with BSA), it was found in all  layers of the 
GBM  (37);  and (c)  the subepithelial  thickening of the GBM  that results from 1080  GLOMERULAR  CHANGES  INDUCED  BY  PROTEOGLYCAN  ANTIBODIES 
anti-HSPG(GBM)  IgG binding is novel.  Injection of anti-type IV collagen or 
anti-laminin IgG also led to GBM thickening, but the patterns were different as 
the binding led to a  uniform thickening of the GBM  (25) in the former or to 
subendotheliai  thickening  in  the  case  of the  latter  (23).  Subepithelial  GBM 
thickening of the type induced by bound anti-HSPG(GBM)  IgG has been de- 
scribed in some types of glomerular nephropathy (e.g., AIport's syndrome) in 
humans (38). 
The induction of subepithelial GBM thickening suggests that the binding of 
anti-HSPG(GBM) IgG disturbs, in ways that are not yet understood, the turnover 
of the GBM. The available evidence based on silver nitrate labeling (39) indicates 
that basement membrane constituents are added to the GBM along the epithelial 
surface and removed along the endothelial-mesangial surface. Normally, synthe- 
sis and removal remain balanced so that a fairly uniform thickness is maintained. 
The turnover of the GBM as a whole (39), as well as of collagenous components 
of the GBM (40), is very slow (6-12 too), whereas the turnover of the sulfated 
glycosaminoglycan side  chains  of proteoglycans  isolated  from  whole  kidney 
cortex (41) or the GBM (42) is much more rapid (3-5 d). We have previously 
obtained autoradiographic (2) and immunocytochemical (8) evidence indicating 
that,  among  glomerular  cell  types,  the  epithelium  is  the  main  producer  of 
basement membrane HSPG. Apparently the binding of antibodies to these HSPG 
perturbs the deposition and/or removal of GBM components and leads to the 
accumulation of a new and thicker GBM layer. Whether this is due to increased 
biosynthesis of GBM components by the epithelium or decreased degradation 
(removal) of old basement membrane cannot be determined from the informa- 
tion at hand.  Biosynthetic studies on the synthesis and turnover of HSPG and 
other GBM components after radiolabeling are required to define more precisely 
the nature of the metabolic defects involved. 
The anti-HSPG(GBM) IgG remained bound to the laminae rarae and demon- 
strable  by  immunoperoxidase staining  up  to  2  mo postinjection.  The bound 
immune complexes did not form the large, electron-dense aggregates character- 
istic of membranous nephritis. This resembles the situation seen after injection 
ofanti-laminin antibodies (23), but it is quite different from that seen in Heymann 
nephritis (43-45) or after implantation of nonrenal antigens such as cationized 
proteins  (46).  The difference can  undoubtedly be  explained by the fact that 
immune complexes must undergo condensation and aggregation to form large 
electron-dense deposits (47, 48), and those formed from implanted cationized 
antigens (46) or gp330 (the Heymann nephritis antigen) (14) are capable of such 
rearrangements (45),  whereas complexes formed with GBM  antigens, such as 
basement membrane HSPG,  are not,  presumably because they remain firmly 
fixed to the GBM. 
These observations help us understand the pathogenesis of human glomerular 
nephropathy because they show that the consequences of antibody binding to 
the GBM, i.e., whether resulting in an anti-GBM (12) or immune complex (I I) 
type of nephropathy, do not depend on the original location of the antigen (LRI, 
LRE, lamina densa, or epithelial cell surface) or on whether it is exogenous or 
endogenous.  The outcome depends instead on  whether the antigen  is  firmly MIETT1NEN  ET  AL.  1081 
fixed or free, allowing for molecular rearrangement (45, 47, 48) of the resultant 
immune complexes after binding antibody. 
Another aspect of our findings which may be instructive is the demonstration 
that  the  transient  presence  of circulating  antibodies  that  recognize  a  single 
basement membrane constituent can, in a clinically rather nonflamboyant, silent 
manner,  initiate GBM thickening, a change commonly seen in human nephrop- 
athy. Furthermore, the recent finding of anti-HSPG antibodies in sera of human 
patients (6) raises the intriguing possibility that circulating anti-HSPG autoanti- 
bodies could be the direct causative agent responsible for glomerular disease in 
some patients. 
Summary 
Antibodies specific for the core protein of basement membrane HSPG (Mr = 
130,000) were administered to rats by intravenous injection, and the pathologic 
consequences on the  kidney were determined  at  3  min to  2  mo postinjection. 
Controls were given antibodies against gp330 (the pathogenic antigen  of Hey- 
mann nephritis) or normal rabbit IgG. 
The  injected  anti-HSPG(GBM)  IgG  disappeared  rapidly  (by  1  d)  from  the 
circulation.  The  urinary  excretion  of albumin  increased  in  a  dose-dependent 
manner  during  the  first 4  d,  was increased  10-fold at  1-2  mo,  but remained 
moderate (mean =  12 mg/24 h).  By immunofluorescence the anti-HSPG(GBM) 
was seen to bind rapidly (by 3 rain) to all glomerular capillaries, and by immu- 
noperoxidase staining the anti-HSPG was seen to bind exclusively to the laminae 
rarae of the GBM where it remained during the entire 2-mo observation period. 
C3  was detected in glomeruli  immediately after the injection (3 min),  where it 
bound exclusively to the lamina rata interna; the amount of C3 bound increased 
up to  2  h  but decreased  rapidly thereafter,  and  was not detectable after  4  d. 
Mononuclear  and  PMN  leukocytes accumulated  in  glomerular  capillaries,  ad- 
hered to the capillary wall, and extended pseudopodia through  the endothelial 
fenestrae to contact in the LRI of the GBM where the immune deposits and C3 
were located. At 1 wk postinjection, staining for C3 reappeared in the glomeruli 
of some of the rats, and by this time most of the rats, including controls injected 
with normal  rabbit IgG,  had circulating anti-rabbit  IgG (by ELISA) and linear 
deposits of rat IgG along the GBM (by immunofluorescence).  Beginning at 9 d, 
there was progressive subepithelial thickening of the GBM which in some places 
was two to three times its normal  width.  This thickening was due to the laying 
down of a new layer of basement membrane-like material on the epithelial side 
of the GBM, which gradually displaced the old basement membrane layers toward 
the endotbelium. 
The  results  show  that  the  core  proteins  of  this  population  of  basement 
membrane HSPG (Mr =  130,000), which are ubiquitous components of basement 
membranes, are exposed to the circulation and can bind anti-HSPG(GBM) IgG 
in the laminae rarae of the GBM. Binding of these antibodies to the GBM leads 
to  changes  (C3  deposition,  leukocyte adherence,  moderate  proteinuria,  GBM 
thickening) considered typical of the acute phase of anti-GBM glomerulonephri- 
tis. Antibody binding interferes with the normal turnover of the GBM, presum- 1082  GLOMERULAR  CHANGES  INDUCED  BY  PROTEOGLYCAN  ANTIBODIES 
ably by affecting the  biosynthesis  and/or  degradation  of basement  membrane 
components. 
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